SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

Shiba Inu is seeing renewed community buzz as some traders attempt to orchestrate short squeezes and push for a reversal, despite ongoing skepticism regarding the token's massive circulating supply and historical performance. While some long-term holders remain focused on the ecosystem's potential and burn mechanisms, the broader market discourse reflects a divide between speculative optimism and frustration over price stagnation.

Sweetgreen, Inc. owns and operates a chain of salad restaurants. It offers drinks, sides, local bowls, salads, plates, and warm bowls. The company was founded by Nicolas Jammet, Jonathan Neman, and Nathaniel E. Ru in November 2006 and is headquartered in Los Angeles, CA.

Sweetgreen Inc - Ordinary Shares - Class A

Sweetgreen is trending as investors react to a significant upgrade from JP Morgan and social media momentum surrounding its new viral wrap menu. While the community remains divided over its long-term financial viability and historical profitability, recent volume spikes and institutional activity have fueled speculation about a potential short squeeze.

Curaleaf Holdings, Inc. operates as a holding company with interest in medical and wellness cannabis operations. It operates through the Domestic Operations and International Operations segments. The company was founded on November 13, 2014 and is headquartered in Stamford, CT.

Curaleaf Holdings Inc

Curaleaf is currently in focus as the community debates potential legislative catalysts, specifically the possibility of federal rescheduling and the impact of the ongoing DEA hearing on the broader cannabis market. Investors remain keenly focused on the stock's role as a major U.S. operator with a significant international footprint, actively discussing how institutional accumulation during recent volatility could position the company for growth if regulatory obstacles are removed.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is seeing intense volatility and social media debate as traders react to the disclosure and subsequent patch of a critical vulnerability in its Orchard privacy protocol. While some community members are treating the dip as a significant buying opportunity, others are expressing concern over the project's long-term transparency and the potential for previous undetected exploits.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondo is trending as investors debate the potential for RWA tokenization to disrupt traditional finance, with community members highlighting its role as a governance-focused asset while debating the impact of future fee-switch proposals. Discussions are heavily centered on the asset's long-term utility versus its short-term supply dynamics, as traders look toward regulatory catalysts to drive the next major wave of institutional adoption.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

AbbVie Inc. is trending as investors weigh recent regulatory developments and M&A activity, including the acquisition of Apogee Therapeutics to bolster its immunology pipeline. Market conversation is currently focused on the company's ability to maintain growth in Skyrizi and Rinvoq sales to offset patent-related revenue headwinds.

ProShares Trust II - ProShares UltraShort Bloomberg Crude Oil -2x Shares

ProShares UltraShort Bloomberg Crude Oil

ProShares UltraShort Bloomberg Crude Oil (SCO) is attracting heavy attention as traders bet on a potential reversal in crude prices amid conflicting reports regarding peace deals and supply chain disruptions in the Strait of Hormuz. The community is sharply divided, with many actively trading the volatility through short-term swings while others debate the impact of share price decay and upcoming reverse stock splits on the ETF's long-term viability.

OpenAI

OpenAI is trending as investors monitor ongoing IPO deliberations and the company's aggressive infrastructure spending, while community discussion focuses on the firm's strategic partnerships and competitive positioning against Anthropic. Market participants are also weighing the potential impact of high-profile legal challenges and the broader implications of AI-driven token costs on the tech sector.

TRUMP is a politics-themed digital coin built on the Solana blockchain that uses the brand of Donald Trump to foster a community-driven ecosystem. As a community-focused asset, it is designed to bridge political support with web ownership, operating within the PolitiFi sector to blend political movements with decentralized finance tools. The project's main value proposition lies in its official ties to Donald Trump’s media and business brands, which allows it to provide unique physical utility such as invitations to gala dinners and meetings at Mar-a-Lago.  The token serves as the primary currency for the officially licensed Trump Billionaires Club mobile and web game, where it is used for in-game purchases and unlocking features. By leveraging the Solana blockchain, the project ensures that these in-game actions and token transfers remain fast and cost-effective. The ecosystem remains stable through a programmatic release schedule that introduces new tokens slowly to prevent supply shocks, alongside the use of specialized market makers to maintain consistent liquidity for traders.  Holders can also participate in liquidity sharing by providing their tokens to automated systems to facilitate trading for others, often earning rewards or prizes in return. Beyond digital utility, holding a specific amount of the token is a requirement for attending exclusive real-world events, including VIP parties at Mar-a-Lago. The project is managed by the Trump Meme Team and is linked with Trump Media, with an investor base that includes a wide range of retail buyers and large holders who utilize secure custody services for their assets.

Trump For President

The $TRUMP token is facing intense scrutiny as investors grapple with significant losses, while community discourse remains polarized between supporters betting on a speculative short squeeze and critics labeling the asset a high-profile grift. The conversation is heavily driven by reports of massive retail losses alongside the broader political debate surrounding Trump's crypto-related ventures and their impact on market sentiment.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending due to mounting investor optimism surrounding its QNX operating system, which is increasingly recognized as a foundational safety layer for physical AI in robotics, autonomous vehicles, and industrial automation. The community is actively discussing the strategic potential of the Alloy Kore platform, with many investors anticipating imminent design win announcements and highlighting the company's deepening collaborations with major silicon providers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Trending Stock Hims & Hers Health, Inc. (HIMS) a Buy Now?

Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

FDA Panel Narrowly Backs Four Peptides  Hims & Hers Stock in the Spotlight

Hims & Hers Health is in focus Friday after an FDA advisory panel on Thursday recommended adding four peptides to a federal compounding list.read more...

HIMS Stock Climbs Overnight As FDA Advisory Panel Backs 4 Peptides — ‘Pharma Bro’ Martin Shkreli Goes Short 

Equity

Leerink sees a $2.2 billion peptide market, with Hims potentially capturing about 20%.

Nasdaq, S&P 500, Dow Futures Shake Off Iran Jitters As Investors Turn To AI Hyperscaler Earnings: INTC, TSLA, TTD, HIMS In Focus

Markets were primarily focused on earnings from major companies, alongside rising oil prices due to the continued tensions between the U.S. and Iran. 

Why Is Hims & Hers Health Stock Surging on Thursday?

Hims & Hers Health Inc (NYSE: HIMS) stock surges Thursday after an FDA advisory committee votes on adding BPC-157 to the allowed pharmacy compounding list.read more...

Why Is HIMS Stock Rallying 13% Today?

An FDA advisory panel on Thursday recommended adding the peptide BPC-157 to a list that would allow compounding pharmacies to prepare it more freely for patients. 


Hims & Hers Health, Inc. (HIMS) Suffers a Larger Drop Than the General Market: Key Insights

Hims & Hers Health, Inc. (HIMS) closed the most recent trading day at $31.68, moving 3.21% from the previous trading session.

HIMS Stock Snaps 3-Day Losing Streak: FDA Adds 8 New Peptide Voters Deemed ‘More Qualified And Less Conflicted’ 

The new panelists bring expertise in neurology, pain, dermatology, gastroenterology, addiction, cancer pharmacology and patient advocacy.

Here's How Much You Would Have Made Owning Hims & Hers Health Stock In The Last 5 Years

Hims & Hers Health (NYSE:HIMS) has outperformed the market over the past 5 years by 20.67% on an annualized basis producing an average annual return of 31.83%. Currently, Hims & Hers Health has a marketread more...

HIMS Stock On A 3-Day Slide: CFO Cashes Out $229K In Shares Ahead Of FDA Peptide Meeting 

The next major catalyst is the FDA’s July 23-24 advisory committee meeting, where regulators will consider whether seven peptides should be added to the Section 503A Bulks List.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Extremely Bullish Sentiment

Favorable

Unfavorable

Delayed

Hims & Hers ($HIMS) is bracing for a pivotal FDA advisory meeting on July 23-24 that will decide whether seven peptides get added to the compounding list. How do you think the FDA rules? Vote and explain your reasoning in the comments.

The FDA is deciding whether to add peptides to the compounding list, a ruling that could be huge for $HIMS. How do you think it goes?

Stocktwits

Hims & Hers Health Inc

The FDA is deciding whether to add peptides to the compounding list, a ruling that could be huge for 

Stocktwits Polls

Investors are navigating FDA advisory panel volatility as hopes for regulatory-approved compounding unlock major new revenue streams.

High short interest creates massive tension, with bullish traders betting on an explosive reversal fueled by rapid position covering.

Frustrated shareholders are debating whether the recent double-digit drop is standard market 'sell the news' behavior or unfair manipulation.

Many retail traders view the sharp correction as a golden discount opportunity to accumulate shares for long-term growth.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	-$0.05	--	--	N/A
Q1 '26	$0.03	-$0.40	-1676.48%	MISSED
Q4 '25	$0.04	$0.08	100.62%	BEAT
Q3 '25	$0.09	$0.06	-36.40%	MISSED
Q2 '25	$0.15	$0.17	12.73%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

HIMSHims & Hers Health Inc

Upcoming Earnings: Q2 '26

Historical Earnings

Latest HIMS News